Reuter V - Search Results

1

Is year of radical prostatectomy a predictor of outcome in prostate cancer?

Cagiannos I, Karakiewicz P, Graefen M, Eastham JA, Ohori M, Rabbani F, Reuter V, Wheeler T, Kupelian P, Klein E, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen M, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: reuter v. J Urol. 2004 Feb;171(2 Pt 1):692-6. doi: 10.1097/01.ju.0000107260.98031.0e. J Urol. 2004. PMID: 14713788

2

Neoadjuvant hormonal manipulation: a strategy for chemoprevention trials.

Fair WR, Aprikian A, Reuter V. Fair WR, et al. Among authors: reuter v. J Cell Biochem Suppl. 1992;16H:118-21. doi: 10.1002/jcb.240501227. J Cell Biochem Suppl. 1992. PMID: 1289666 Review.

3

Perirenal lipoma versus renal cell carcinoma.

Mydlo JH, Shore N, Reuter V, Herr HW. Mydlo JH, et al. Among authors: reuter v. Urology. 1991 Jul;38(1):67-9. doi: 10.1016/0090-4295(91)80019-4. Urology. 1991. PMID: 1866864

4

Absence of structural alterations of the multidrug resistance genes in transitional cell carcinoma.

Klein EA, Allen G, Fair WR, Reuter V, Chaganti RS. Klein EA, et al. Among authors: reuter v. Urol Res. 1990;18(4):281-6. doi: 10.1007/BF00294774. Urol Res. 1990. PMID: 2219592

5

Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.

Fair WR, Scher H, Herr H, Morse M, Sogani P, Bosi G, Dershaw D, Reuter V, Curley T, et al. Fair WR, et al. Among authors: reuter v. Semin Urol. 1990 Aug;8(3):190-6. Semin Urol. 1990. PMID: 2399387 No abstract available.

6

Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.

Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr HW, Whitmore WF, Cordon-Cardo C. Sheinfeld J, et al. Among authors: reuter ve. J Urol. 1990 Feb;143(2):285-8. doi: 10.1016/s0022-5347(17)39935-4. J Urol. 1990. PMID: 2405185

7

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, et al. Scher H, et al. Among authors: reuter v. Br J Urol. 1989 Sep;64(3):250-6. doi: 10.1111/j.1464-410x.1989.tb06008.x. Br J Urol. 1989. PMID: 2804561

8

Primary signet-ring cell carcinoma of urinary bladder.

Bernstein SA, Reuter VE, Carroll PR, Whitmore WF Jr. Bernstein SA, et al. Among authors: reuter ve. Urology. 1988 May;31(5):432-6. doi: 10.1016/0090-4295(88)90744-3. Urology. 1988. PMID: 2834858 Review.

9

Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin).

Hermansen DK, Reuter VE, Whitmore WF Jr, Fair WR, Melamed MR. Hermansen DK, et al. Among authors: reuter ve. J Urol. 1988 Dec;140(6):1394-6. doi: 10.1016/s0022-5347(17)42053-2. J Urol. 1988. PMID: 3193503

10

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RC, Dershaw DD, Reuter V, et al. Scher HI, et al. Among authors: reuter v. J Urol. 1988 Mar;139(3):470-4. doi: 10.1016/s0022-5347(17)42495-5. J Urol. 1988. PMID: 3343728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

741 results

Search Page

Filters